US FDA, HHS Leadership Push Broader Testosterone Indication At Expert Panel

 
• By Sarah Karlin-Smith
  
FDA Commissioner Markary
FDA Commissioner Martin Makary spoke Dec. 10 during the agency's expert panel on testosterone replacement therapy for men. (US FDA livestream)

More from US FDA

More from Agency Leadership